Physician profile
Ramiah Krishnan
NPI 1619923885
$1,075.82
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $633 · 2021: $79.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $352.65 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $86.44 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $69.34 | 2020 | |
| Amarin Pharma, INC. | $68.75 | 2019-2020 | |
| Novo Nordisk INC | $66.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $54.17 | 2019-2021 | |
| Amgen INC. | $49.13 | 2019-2021 | |
| Adlon Therapeutics L.P. | $49.02 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $39.69 | 2020 | |
| Novartis Pharmaceuticals Corporation | $38.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.25 | 2020 | |
| Lilly USA, LLC | $27.43 | 2020 | |
| Eisai INC. | $21.92 | 2020 | |
| Daiichi Sankyo INC. | $21.11 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.09 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.36 | 2019 | |
| Metuchen Pharmaceuticals | $15.34 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.64 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.39 | 2019 | |
| Allergan, INC. | $12.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramiah Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.